RSV: Recommended vaccinations
  General recommendation
  Recommendation for specific groups only
  Catch-up (e.g. if previous doses missed)
 
Vaccination not funded by the National Health system
 
Mandatory vaccination
Years
15184559606465-74≥ 75
Austria
RSV1
Belgium
RSV2
RSV3
Bulgaria
RSV4
Croatia
Cyprus
Czechia
Denmark
RSV5
Estonia
Finland
France
RSV6
RSV7
RSV
Germany
RSV7
RSV
Greece
Hungary
Iceland
Ireland
Italy
Latvia
Liechtenstein
Lithuania
Luxembourg
RSV6
Malta
Netherlands
Norway
RSV8
Poland
RSV
Portugal
Romania
Slovakia
Slovenia
RSV9
Spain
RSV10
Sweden
RSV11
RSV11

Footnotes:

  1. More information: https://impfen.gv.at/impfungen/rsv or https://www.sozialministerium.gv.at/impfplan (p. 110ff)
  2. The vaccine is recommended and partially reimbursed for pregnant women between gestational weeks 28 and 36 as part of a combined strategy with monoclonal antibodies. It is typically administered as a single-dose program during the autumn and winter seasons.
  3. Vaccine recommended to adults >60 years of age with comorbidities (partially reimbursed) and adults =75y (not reimbursed if no comorbidities): https://www.hgr-css.be/fr/avis/9837/vaccination-contre-le-vrs-adultes-revision-2022
  4. Immunization of pregnant women between 24 and 36 weeks of gestation. Vaccine and the administration are free of charge for pregnant women and funded by the National Health system.
  5. Vaccination during pregnancy. See https://www.ssi.dk/vaccinationer/vaccination-af-gravide
  6. The vaccine is offered to pregnant women between gestational weeks 32 and 36 as part of a combined strategy with monoclonal antibodies. It is typically administered as a single-dose program during the autumn and winter seasons.
  7. Vaccine offered only to patients with risk factors.
  8. RSV-vaccine is recommended in pregnancy, but not part of the national vaccination program and costs are not covered.
  9. The vaccine is offered to pregnant women between gestational weeks 24 and 36. It is administered as a single-dose program all year round.
  10. Vaccination recommeded to specific risk groups. More information available at: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_Todalavida.pdf and https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/VRS/poblacionAdulta/docs/VRS_adulto_Actualizacion.pdf
  11. Vaccination is recommended for all people aged 75 and over. Vaccination is recommended for people aged 60 and over with certain diseases, diagnoses or conditions. More information available at: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/vaccinationer/rekommendationer-for-vaccination/